Protocol described for obtaining hepatic stellate cells from stem cells

by Fundació Clínic per a la Recerca Biomèdica

3 years ago
IDIBAPS, hepatic stellate cells, stem cells, IDIBAPSLiver, Liver fibrosis, Chronic liver disease

IDIBAPS researchers have published in Nature Protocols the process for the directed differentiation of human induced pluripotent stem cells (iPSCs) into hepatic stellate cells (iPSC-HSCs).

Sartorius Partners With RoosterBio to Advance Cell and Gene Therapy Manufacturing

by Sartorius Stedim Spain

3 years ago
stem cells, regenerative medicine, life science, Gene Therapy, RoosterBio

The life science company Sartorius signed a strategic collaboration with RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cell (hMSC) working cell banks, highly engineered media a...

Blood vessels communicate with sensory neurons to decide whether they remain as a reservoir of stem cells or differentiate

by UPF - Universitat Pompeu Fabra

4 years ago
regenerative therapies, blood vessels, sensory neurons, stem cells

The researchers, using real-time videos, have discovered that both the neurons and the cells of blood vessels emit dynamic protrusions to be able to ‘talk’ to each other.

A quick and simple technology to improve the effectiveness of stem cells in regenerative medicine developed

by CNIO - Centro Nacional de Investigaciones Oncológicas

4 years ago
stem cells, regenerative medicine, technology

Stem cells have been holding great promise for regenerative medicine for years. In the last decade, several studies have shown that this type of cell, which in Spanish is called “mother cell” beca...

Asphalion participated in the nTRACK 30 MM follow up e-meeting

by Asphalion

4 years ago
e-meeting, stem cells, biodistribution

Last week , our colleagues Marta Rayo and Marta Morales participated in the nTRACK 30 MM follow up meeting to discuss the project progress with all the partners.

Stem cells treatment for fistulas in Crohn’s disease is about to be approved in Catalonia a

by Fundació Clínic per a la Recerca Biomèdica

5 years ago
Stem cells, fistulas, Crohn’s disease

Treatment with mesenchymal stem cells (MSCs), extracted from fat tissue, is a powerful tool for the cure of autoimmune diseases such as Crohn’s disease.

The eyes: excellent candidates for stem cell therapies

by Fundació Clínic per a la Recerca Biomèdica

5 years ago
eyes, cell therapy, gene therapy, stem cells, regeneration of the cornea, implant cells

Replacing the cells of a damaged tissue with healthy ones using stem cells is now a reality.

Therapeutic use for stem cells in the dental pulp?

by Achucarro Basque Center for Neuroscience

5 years ago
dental pulp, stem cells, vascular therapies

A collaboration research between Achucarro and the UPV/EHU discovers that dental pulp stem cells are able to integrate and generate brain neovasculogenesis

Interview Valles Visio: Nanoligent

by Hospital de la Santa Creu i Sant Pau

5 years ago
Biotechnology, Biomedicine, drug, stem cells, metastatic

In June 2017, researchers from the IIB-Sant Pau, the Institute of Biotechnology and Biomedicine at the UAB and the CIBER-BBN, created a spin-off, Nanoligent, with the goal of developing the first drug...

BigH1—the key histone for male fertility

by IRB Barcelona - Instituto de Investigación Biomédica

6 years ago
histone BigH1, male sex cells, stem cells, infertility

Researchers at IRB Barcelona unravel the role of the histone BigH1 in the development of male sex cells from stem cells. The study, which was performed in Drosophila melanogaster, paves the way to a ...

A genome-editing strategy to study cancer stem cells in human tumours

by IRB Barcelona - Instituto de Investigación Biomédica

7 years ago
CRISPR/Cas9 genome, colorectal cancer, stem cells, LGR5+

In EMBO Molecular Medicine, IRB Barcelona scientists report a technique based on a combination of CRISPR/Cas9 genome editing and patient-derived tumour organoids that allows the study of cell heteroge...

Takeda and TiGenix report new data highlighting maintenance of long-term remission of complex perianal Fistulas in Crohn’s disease patients with Cx601

by TIGENIX SAU

7 years ago
Phase 3 ADMIRE-CD clinical trial, stem cells, compound Cx601, perianal fistulas, Crohn’s disease

Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and TiGenix NV (Euronext Brussels and Nasdaq: TIG) (“TiGenix”) today announced new data from the Phase 3 ADMIRE-CD clinical trial, ...